Ionizing Radiation-treated NRF2-deficient Cancer Cells Promote Type I Interferon Signaling in Immune Cells
Anticancer Research · 2024
DOI: 10.21873/anticanres.17063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Hye-Ran Seo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Interferon Type I, Signal Transduction, Radiation, Ionizing.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
- Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea ahnjy@kirams.re.kr.
Zitieren
APA
Seo, H. R., Kim, H. J., Ryu, H., Song, J. Y., Hwang, S. G., & Ahn, J. (2024). Ionizing Radiation-treated NRF2-deficient Cancer Cells Promote Type I Interferon Signaling in Immune Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17063
Vancouver
Seo HR, Kim HJ, Ryu H, Song JY, Hwang SG, Ahn J. Ionizing Radiation-treated NRF2-deficient Cancer Cells Promote Type I Interferon Signaling in Immune Cells. Anticancer Research. 2024. doi:10.21873/anticanres.17063
BibTeX
@article{Seo2024,
author = {Seo, Hye-Ran and Kim, Hyo Jeong and Ryu, Hwani and Song, Jie-Young and Hwang, Sang-Gu and Ahn, Jiyeon},
title = {Ionizing Radiation-treated NRF2-deficient Cancer Cells Promote Type I Interferon Signaling in Immune Cells},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17063}
}
EUVIMED